GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 41.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.878%)
Open: 42.00
High: 42.00
Low: 42.00
Prev. Close: 42.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Eneraqua shares plunge on annual profit warning

Wed, 11th Oct 2023 10:52

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Power Metal Resources PLC, up 8.8% at 0.68 pence, 12-month range 0.55-1.85p. The metals exploration and development company reports that extensive radon gas sampling at the Tait Hill and Soaring Bay projects in and around the Athabasca Basin in Saskatchewan, Canada, have confirmed multiple significant uranium targets. Chief Executive Sean Wade says this season's uranium fieldwork continues to surpass the firm's expectations in terms of quality and number of significant targets discovered. "Following very low acquisition costs, we believe we are now adding very considerable value to a portfolio with well thought out, methodical and inexpensive exploration, clearly demonstrating the ongoing success of our business model. We now look forward to the next stage, that of crystallising the value created for our shareholders. We are in discussion with various third parties about ways in which we can do that, and I look forward to updating shareholders on those discussions in due course," the CEO adds.

----------

Cambridge Cognition Holdings PLC, up 6.7% at 74.70 pence, 12-month range 65.35-129.74p. The company wins a "significant" GBP1 million contract for a "sizeable" later stage clinical trial, following a competitive tender. The contract combines the company's Cantab touch-screen cognitive assessments with verbal assessments from its recent Winterlight Labs acquisition. Cambridge Cognition will supply its electronic clinical outcome assessments and provide full training for clinicians, together with quality control services, as part of the contract. Revenue from the contract is expected to be recognised over a two-year period, starting in 2023. Notes there is potential for a further contract with the same customer, of "slightly" higher value, in 2024 once the initial results have been analysed. Cambridge Cognition develops and markets digital solutions to assess brain health.

----------

AIM - LOSERS

----------

Eneraqua Technologies PLC, down 58% at 39.00 pence, 12-month range 38.26-389.60p. The energy and water efficiency solution provider swings to an interim loss amid rising costs and warns of a "material reduction" in profitability in the full-year. Pretax loss in the six months ended July 31 totals GBP441,000, swinging from a profit of GBP3.0 million the year prior. Loss comes as the company records a 20% rise in its cost of sales to GBP17.2 million, and a 31% rise in administrative expenses to GBP9.0 million. The rising costs offsets growth in revenue which rises 7.4% to GBP26.0 million from GBP24.2 million. Chief Executive Mitesh Dhanak adds: "Post-period end the group has faced dual headwinds. The continued and increased budgetary pressures on local government are leading to discussions on slowing down project delivery and deferring works into [financial 2025]. This compounds the impact of the recent unexpected [UK] government policy change in relation to net nutrient neutrality. As a result, the board now expects some projects to be delivered more slowly with revenues moving into next year and reduced operational leverage affecting margins. As a result we expect to see a material reduction in revenues and outturn in profitability during [financial 2024]."

----------

Jubilee Metals Group PLC, down 11% at 6.26 pence, 12-month range 6.01-13.92p. The metal processing company reports that its annual profit more than halved as surging overhead costs put margins under pressure. Posts a pretax profit of GBP12.3 million in the financial year ended June 30, down 54% from GBP26.5 million a year earlier. Profit margins shrink to 22% from 32%, as costs balloon. Cost of sales grow by 17% to GBP110.5 million from GBP94.6 million. Finance costs multiply to GBP5.2 million from GBP1.4 million. Jubilee reports revenue of GBP141.9 million, up slightly 1.4% from GBP140.0 million, with growth in dollar-denominated chrome revenue predominately offsetting a decrease in platinum group metal revenue. Notes that PGM price is now trading at USD1,359 an ounce, which is 46% below the 2022 financial average and 21% below average in the 2023 financial year.

----------

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
29 Sep 2014 11:54

DIRECTOR DEALINGS: Cambridge Cognition CEO And CFO Buy Shares

Read more
24 Sep 2014 08:58

DIRECTOR DEALINGS: Cambridge Cognition CEO And CFO Buy Shares

Read more
11 Sep 2014 10:21

Cambridge Cognition Narrows Pretax Loss In First-Half

Read more
13 Aug 2014 09:28

Cambridge Cognition Expands Partnership With Altreos Research

Read more
2 Jul 2014 08:50

Cambridge Cognition To Meet Full-Year Expectations As Half Year Ahead

Read more
26 Jun 2014 09:50

Cambridge Cognition Confident For Full-Year On Contract Wins

Read more
5 Jun 2014 09:34

Cambridge Cognition Holdings Signs Contracts For Cognitive Safety Trial

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Thursday that it has signed a contract for a global multi-year study in which its Cantab Solutions technology will be used to assess the cognitive safety of a new medicine under development for cardiovascular disease. The contra

Read more
3 Jun 2014 08:12

Cambridge Cognition Launches First iPad Product For Clinical Trials

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Tuesday that it had launched the first of its two iPad-based products on its Cantab Connect digital platform for use in clinical trials. Its product, called The Clinical Trials Information System Adverse Effects, allows for the

Read more
28 May 2014 10:08

Cambridge Cognition rolls out new health app in Lincolnshire

Computerised neuropsychological test specialists Cambridge Cognition announced its Cantab Mobile app has been released by North East Lincolnshire Clinical Commissioning Group into the medical sector. The group's app will be introduced to five GP surgeries, five pharmacies and Grimbsy hospital to he

Read more
28 May 2014 10:00

Cambridge Cognition Mobile App Rolled Out In North East Lincolnshire

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday that the North East Lincolnshire Clinical Commissioning Group has introduced its Cantab mobile app in five GP surgeries, five pharmacies and Grimsby hospital to help diagnose dementia earlier. The firm, which specialis

Read more
8 May 2014 11:58

Cambridge Cognition Reiterates Confidence On Return To Growth

LONDON (Alliance News) - Cambridge Cognition Holdings PLC Thursday reiterated confidence that it would be able to return to growth in 2014, in a statement ahead of its annual general meeting. The biotechnology company said that it had seen a positive start to trading in the first quarter of

Read more
2 Apr 2014 10:29

Cambridge Cognition Appoints Non-Executive Chairman

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Wednesday it has appointed Michael Lewis as non-executive Chairman. The company, which specialises in computerised neuropsychological tests including those enabling the early detection of dementia, said Lewis will take over from

Read more
13 Mar 2014 12:08

Cambridge Cognition Confident For Return To Growth In 2014

LONDON (Alliance News) - Cambridge Cognition Holdings PLC expressed confidence Thursday that it would return to growth in 2014, after it posted a widened pretax loss in 2013 due to lower revenue. Cambridge Cognition provides computerised neuropsychological tests, particularly to enable earl

Read more
3 Mar 2014 11:00

Cambridge Cognition Launches Latest Research Software

LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Monday it has launched the Cantab Research Suite, the latest offering in its cognitive testing platform for academic research. Cambridge, which specialises in computerised neuropsychological tests, such as those enabling the ear

Read more
26 Nov 2013 14:14

Cambridge Cognition Holdings Says Pharmaceutical Arm Struggling, Remains Confident Looking Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.